Evidence Paper Review

 Quick Explanation Copied

 Long Explanation

Core Contribution and Evidence

Gervaix et al. built pLTR-GFP by cloning a 530-bp HIV-1 NL4-3 LTR upstream of humanized S65T GFP, electroporated it into CEM CD4+ T cells, and cloned by limiting dilution to remove high-background clones CEM-GFP construct and selection methods. Upon HIV-1 LAI infection, fluorescence rose 100–1,000-fold over 2–4 days, peaking at a 2-log increase by day 4, tracked by microscopy, cytofluorimetry, and flow cytometry in parallel with p24 ELISA Infection kinetics and gp120 correlation. Specificity controls were adequate for the era: psoralen-UV-inactivated virus induced no GFP, TNF-α/PMA gave only 2–3.5-fold activation versus >100-fold with infection, and <5% of GFP+ cells were gp120-negative Specificity controls for GFP induction.

Drug Susceptibility Validation

The key validation compared IC50s from CEM-GFP cytofluorimetry against historical HeLa-CD4 plaque/p24 values for an AZT-sensitive (H112-2) and isogenic AZT-resistant (G910-6) isolate from the same patient:

Nevirapine, saquinavir, tat inhibitor Ro24-7429, and cyclophilin-binding SDZ811 all gave IC50s equivalent to p24/plaque assays Drug susceptibility validation across drug classes. A clever use: 1 μM saquinavir blocks second-round infection, so GFP+ cell counts at MOI 0.06–0.25 (6.0–21.7%) measured single-round infectivity, correlating with plaque titer; correlation degraded at MOI ≥0.5 due to cell-cycle-dependent replication and apoptosis Single-round infectivity titration with saquinavir.

Critical Appraisal, Limitations, and Blind Spots

• Cell-line confinement: CEM lacks CCR5, so the assay was restricted to syncytium-inducing (X4-tropic) strains; the authors acknowledged this and proposed a CCR5-expressing variant, but did not test primary cells or NSI isolates CCR5 limitation acknowledged by authors.
• LTR activation confound: NF-κB-activating cytokines can drive the LTR; the modest 2–3.5-fold induction controls partially address this, but higher physiological cytokine levels were not systematically titrated — a known unknown for inflamed co-culture contexts.
• Apoptosis artifact: At high MOI, fluorescence declines as infected cells die, so late readouts underestimate infection — a real quantitative bias for high-inoculum experiments.
• Reproducibility: Methods are detailed (primers, PCR conditions, drug concentrations), aiding reconstruction, but no raw data repository exists; validations relied on two reference isolates for AZT and undisclosed n for other drugs.
• Legacy and durability: The line was later distributed and remains in routine use, implying external replication beyond this paper's own figures — but that adoption evidence is not contained in this source and should be treated as plausible inference, not cited fact.

Confidence note: Conclusions rest on in vitro comparisons in one immortalized line; the discordance possibilities (cytokine-driven GFP without replication, or replicating virus without LTR activation in mutants) were only partially excluded. Falsifying tests would be GFP-p24 discordance across diverse isolates, primary cells, and CCR5+ backgrounds.

Best Evidence: GFP Reporter AssaysDesign Validation ExperimentGraph Assay ComparisonRun AI Scientist Analysis

Author Review: Alain GervaixAuthor Review: Douglas RichmanAuthor Review: Flossie Wong-StaalAuthor Review: Jacques CorbeilAuthor Review: Robert GalloAuthor Review: Daniel WestAuthor Review: Lorenzo Leoni

 BGPT Paper Review

Study Novelty

First stable LTR-driven GFP T-cell reporter line for live, non-destructive HIV monitoring and one-round infectivity titration — a genuine methodological advance at publication time, building directly on emerging GFP and CCR5 co-receptor literature.

Scientific Quality

Rigorous for 1997: three orthogonal readouts, inactivated-virus and cytokine controls, isogenic sensitive/resistant pair from one patient. Weaknesses: small validation isolate set, no error statistics on IC50s, undisclosed n for several drug assays, and high-MOI apoptosis confound acknowledged only in passing.

Study Generality

Generalizable platform concept (LTR-driven reporter for any lentiviral transcription readout) but empirically confined to CEM cells and X4-tropic strains; authors explicitly scoped the CCR5 gap.

Study Usefulness

Enabled cheap, rapid, high-throughput 96-well drug susceptibility and infectivity titration that directly replaced expensive p24 ELISA and slow plaque assays; the line was subsequently distributed broadly.

Study Reproducibility

Detailed plasmid construction, primer sequences, selection conditions, and assay parameters allow reconstruction; no public raw data or replicate statistics limit exact verification.

Explanatory Depth

Strong empirical characterization of GFP kinetics, gp120 lag (~1 day), and saquinavir single-round logic, but mechanistic explanation is mostly descriptive — apoptosis, cell-cycle effects, and NF-κB confounds are invoked rather than dissected.